Valuation of Medical Innovation Handling with Uncertainty and Risk
<b>Background:</b> The purpose of this paper is to address how to handle uncertainty when performing an economic valuation of a medical innovation R&D project in orphan diseases from the perspective of the investor. <b>Methods:</b> We describe the specific uncertainty rel...
Saved in:
| Main Authors: | Mark Nuijten, Stefano Capri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-08-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2001-6689/12/3/16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An integrated valuation model for payer and investor
by: Mark Nuijten, et al.
Published: (2022-12-01) -
Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020-01-01) -
Pricing Zolgensma – the world’s most expensive drug
by: Mark Nuijten
Published: (2022-12-01) -
Methodological Aspects of Valuation of Credit Institutions under External Uncertainty
by: A. A. Pomulev, et al.
Published: (2022-12-01) -
Visual Research of Global Orphan Drug from a Bibliometric Perspective
by: Wen X, et al.
Published: (2025-05-01)